Abstract:Abnormal activation of the Wnt signaling pathway is found in 90% of colorectal cancers (CRCs). Secreted frizzled-related protein 4 (sFRP4) serves as an antagonist of the canonical Wnt signaling pathway. Epigenetic alterations, including changes in DNA methylation and histone methylation, may influence the expression of sFRP4. Polycomb group (PcG) proteins are epigenetic transcriptional repressors that selectively repress gene expression by forming polycomb repressive complexes (PRCs). Enhancer of zeste homolog 2 (EZH2), the core component of PRC2, is a histone-lysine N-methyltransferase that interacts with DNA methyltransferases. In the present study, the promoter DNA methylation status of sFRP4 in CRC cell lines was analyzed and the underlying mechanisms of action governing this modification was investigated. Firstly, the DNA methylation status of the sFRP4 promoter in CRC cell lines was assessed using methylation-specific PCR. Subsequently, the mRNA and protein levels of sFRP4 were measured using real-time qPCR and western blot analysis, respectively, to determine whether the DNA methylation status of the sFRP4 promoter is correlated with its transcriptional levels. To screen for important epigenetic modifiers that may regulate the promoter DNA methylation status of sFRP4, the expression levels of PcG proteins were examined by gene array analysis. ChIP-qPCR was performed to test whether the selected PcG proteins directly bind the promoter region of sFRP4. Finally, the downregulated PcG proteins EZH2, chromobox 7 (CBX7) and jumonji and AT-rich interaction domain containing 2 (JARID2) were identified and their association with sFRP4 expression levels and Wnt/beta -catenin signaling pathway activity were investigated. The present study revealed that sFRP4 was hypermethylated in the promoter region and downregulated during the progression of the CRC cell lines from Dukes A to Dukes C. Expression levels of PcG proteins EZH2, CBX7 and JARID2 were upregulated and positively associated with the aberrantly activated Wnt signaling pathway in the CRC cell lines. EZH2, CBX7 and JARID2 were all enriched in the sFRP4 promoter region in CRC cells. EZH2 downregulation did not affect the promoter DNA methylation status of sFRP4 but increased its expression levels and decreased CRC cell proliferation. DNA methylation controls the expression of sFRP4. EZH2 regulates sFRP4 expression without affecting the DNA hypermethylation of the sFRP4 promoter and influences CRC cell proliferation and Wnt/beta -catenin signaling pathway activities.

SFRP4 protein expression is reduced in high grade astrocytomas which is not caused by the methylation of its promoter

Demethylation of the SFRP4 Promoter Drives Gastric Cancer Progression Via the Wnt Pathway.

SFRP2 Induces a Mesenchymal Subtype Transition by Suppression of SOX2 in Glioblastoma

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

Hypermethylation of the RASSF1A gene in gliomas.

The Expression of SALL4 in Patients with Gliomas: High Level of SALL4 Expression is Correlated with Poor Outcome

Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer

Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer

Transcriptional Inactivation of Secreted Frizzled-Related Protein 1 by Promoter Hypermethylation As a Potential Biomarker for Non-Small Cell Lung Cancer.

SFRP4 is a Prognostic Marker and Correlated with Treg Cell Infiltration in Pancreatic Ductal Adenocarcinoma

Ezh2 Regulates Sfrp4 Expression Without Affecting The Methylation Of Sfrp4 Promoter Dna In Colorectal Cancer Cell Lines

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia.

Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.

Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG

Secreted frizzled-related protein 4 and its implications in cancer and apoptosis

Aberrant methylation of secreted frizzled-related protein genes in tissues of colorectal cancer and cancer cell lines

SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma

Promoter Hypermethylation Profile of RASSF1A, FHIT, and Sfrp1 in Intracranial Primitive Neuroectodermal Tumors.

OCT4 is Epigenetically Regulated by DNA Hypomethylation of Promoter and Exon in Primary Gliomas

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas